Background The prognosis of invasive mucinous adenocarcinoma (IMA) remains
controversial and should be clarified by comparison with the International Association for the …

Background The prognostic analysis of lung invasive mucinous adenocarcinoma (IMA) is
deficient due to the lack of a universally recommended histological grading system, leading …

Abstract Introduction In the 2015 World Health Organization classification, invasive
mucinous adenocarcinoma (IMA) is categorized as one of various subtypes of lung invasive …

Background In 2015, the World Health Organization (WHO) announced a new classification
of lung tumors. Mucinous bronchioloalveolar adenocarcinomas were reclassified as …

Objective To investigate the association between CT imaging features and survival
outcomes in patients with primary invasive mucinous adenocarcinoma (IMA). Materials and …

Introduction An invasive mucinous adenocarcinoma (IMA) is a distinct lung adenocarcinoma
variant. The characteristics of stage IV IMAs are relatively unclear since most previous …

Abstract Purpose In 2015, the World Health Organization renamed mucinous
bronchioloalveolar adenocarcinoma as pulmonary invasive mucinous adenocarcinoma …

Objectives Invasive mucinous adenocarcinoma (IMA) has a rare incidence with better
prognosis than nonmucinous adenocarcinoma. We aimed to investigate the prognosis …

Invasive mucinous adenocarcinoma of the lung (IMA) is a unique and rare subtype of lung
adenocarcinoma with poorly defined prognostic factors and highly controversial studies …

Background We investigated the patterns and timing of recurrence and death as well as
prognostic factors based on clinicopathological and radiological factors in patients who …